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Following the demonstration by Beeson that induced tolerance to the pyro- 
genic activity of bacterial endotoxins could be reversed by reticuloendothelial 
system (RES)  "blockade" (1), emphasis has been placed on the importance of 
the  rate of clearance of intravenously injected  endotoxin by the  RES.  Most 
such  studies  have  supported  a  positive  correlation  between  tolerance  and 
accelerated uptake of endotoxin  by the  RES. 
Employing passive transfer techniques,  Beeson  observed that rabbits tolerant to 
the pyrogenic activity of typhoid vaccine cleared  endotoxin more rapidly from the 
circulation  than did normal controls.  Moreover, after tolerance was "abolished" by 
RES blockade with thorotrast, endotoxin clearance  rates declined sharply (1). Atkins 
and Wood (2, 3), employing similar techniques,  confirmed the former findings. Howard 
et al. (4), using a variety of P82-1abeled endotoxin preparations in mice, found that endo- 
toxin administered several days previously induced significant  acceleration of endo- 
toxin clearance and that RES blockade with thorotrast depressed the clearance rates. 
Carey  et  al.  (5),  employing CrSl-labeled  Escherichia  coli endotoxin,  demonstrated 
accelerated clearance of lethal quantities of endotoxin by tolerant rabbits and mice. 
Although  increased  clearance rates of sublethal quantities were also observed, this 
was not considered  significant.  However, subsequent studies by Chedid and Parant 
(6) and by Herring el al. (7), indicated that small quantities of Cr~1-1abeled  endotoxins 
are cleared significantly  more rapidly by tolerant mice and rabbits. Koch-Weser et al. 
(8)  also  reported accelerated clearance  of Cr51-1abeled E.  coli endotoxin in  tolerant 
rabbits, although the dosages  employed were not given.  Reasons for regarding such 
* This study was supported by the Commission  on Epidemiological  Survey of the Armed 
Forces Epidemiological  Board and the International Center for Medical Research and Train- 
ing Program, United States Public Health Service Research Grant No. E 4126. 
Recipient of Career Development Award from the National Institutes  of Health under 
Contract No. HE-K3-15, 237-C1. 
241 242  MECHANISMS OF ENDOTOXIN TOLERANCE. II 
accelerated endotoxin dearance as a major factor in the mediation of tolerance have 
been extensively reviewed by Atkins (9). 
The mechanisms whereby the RES  of the tolerant animal  clears  endotoxin 
more rapidly from  the circulation are not  defined. Of  especial interest is the 
specificity of such accelerated clearance. Recent studies in the rabbit indicate 
that  generalized  increases  in  RES  phagocytic  activity,  as  reflected  by  the 
ability to clear colloidal carbon, are not a  requisite for tolerance to the pyro- 
genic  activity  of  endotoxin.  Moreover,  plasma  from  tolerant  donors  could 
transfer  significant pyrogenic tolerance  without  enhancing  the  ability of  the 
RES  to  clear  colloidal carbon.  It  was  therefore  suggested  that  tolerance  in- 
volves  the  participation  of  opsonins  which  provide  specificity  for  the  ac- 
celerated clearance of endotoxin (10).  The present studies in man,  employing 
the clearance of Ira-labeled aggregated human  serum albumin as one index of 
RES  phagocytic activity, confirm the concept that generalized stimulation  of 
RES phagocytic activity is not a  requisite for the acquisition of high levels of 
tolerance to the pyrogenic activity of endotoxin.  Moreover, the data support 
the importance of specific immunologic mechanisms  in the mediation of such 
tolerance. 
Materials and Methods 
These studies were initiated as part of an overall program designed to evaluate the efficacy 
of typhoid vaccine in man. Volunteers  for these studies were healthy male inmates of the 
Maryland House of Correction,  Jesgup, Maryland. Their ages ranged from 20 to 35. Each 
volunteer was fully apprised of all aspects of the investigation. Complete medical evaluation 
was performed to verify the fitness of each participant. 
All syringes and needles were of the disposable type and were sterile and pyrogen-free. 
Two endotoxin preparations were employed to induce tolerance: Salmonella typhosa endotoxin 
(0-282),1 diluted in pyrogen-free physiologic saline to 0.5/zg/ml, and Pseudomonas endotoxin, 2 
diluted to 10/zg/ml. Both endotoxin preparations were bacteriologically  sterile. The same 
endotoxin suspensions were employed throughout the study. Pyrogen assays of each prepa- 
ration were performed in groups of acclimatized albino rabbits at two different dose levels for 
each endotoxin; no loss of potency was detectable during the course of these investigations. 
The  antigenic properties of these endotoxins  have  been  documented  in  previous studies 
(12, 13). 
Pyrogen Assay in Man.--All assays were begun between 9 and 10 a.m. with the subjects 
confined to bed and covered with a light blanket. Flexible thermocouples  were inserted into 
the rectum for fixed distances (6 inches) and temperatures recorded  by means  of a  telether- 
mometer (Yellow Springs Instrument Company, Yellow Springs, Ohio). Temperatures were 
monitored immediately prior to and every half hour for 7 hours following the intravenous 
injection of endotoxin. The resulting fever index was calculated from the area under the curve 
obtained by plotting the increment in temperature as a function  of time on standard graph 
1 A highly purified  material (11) kindly supplied by Dr. Manrice Landy, National Insti- 
tutes of Health, Bethesda. 
* Kindly supplied as Piromen® by Dr. Thomas A. Garrett, Baxter Laboratories, Morton 
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paper; a fever index of 100 reflected a I°F rise in rectal temperature sustained for 1 hour. As a 
result  of diurnal  variation,  temperatures  seldom returned  to preinjection values.  In such 
instances, the fever curves were extrapolated to the baseline. The subjective reactions to the 
endotoxins (headache, chills, myalgia, anorexia) were gradedas follows: 1+, mild; 2+, moder- 
ate; 3+, severe; 4+, extremely severe. 
Assay of RES Pttagocytic Acti~i~y.--RES  phagocytic activity was assessed  with a colloidal 
preparation of heat-aggregated I181-1abeled  human serum albumin. The method of preparation 
of this material and  the evidence that  its clearance in man after intravenous injection is a 
function of RES phagocytic activity have been detailed previously (14).  Table I  lists the 
characteristics of the aggregated albumin preparation.  The distribution of the radioactivity 
in the liver can be seen in the scintillation scan of a normal subject following the administra- 
tion of 0.025 mg/kg (Fig. 1). Fig. 2 shows the concentration of radioactivity in both the liver 
and spleen following a 50 mg/kg dose. Prior studies in animals have shown that the clearance 
of such aggregated albumin particles parallels that of coUoidal carbon (15)' Moreover, since the 
aggregated albumin is rapidly metabolized by the RES (16), repeated determinations of RES 
phagocytic activity can  be performed with high levels of safety and  reproducibility  (14). 
Serial baseline control studies of RES phagocytic activity were obtained prior to endotoxin 
TABLE I 
Characteristics of I181-Labded Aggregated Human Serum Albumin 
1.  An aggregate of approximately  10 albumin molecules. 
2.  Distributed  in  a  manner  characteristic  of RES  phagocytized  particles;  trace 
doses concentrated in the liver, large doses in both liver and spleen; virtually no 
uptake by circulating buffy coat. 
3.  Rapidly metabolized after phagocytosis. 
4.  Not antigenic to man. 
5.  Not associated with excessive radiation. 
administration.  For this purpose,  5 mg/kg of I131-1abeled aggregated albumin was injected 
intravenously, and the time required for plasma clearance (T~) was calculated by methods 
previously outlined (14). This value was employed as one index of RES phagocytic activity; 
increases reflect impaired phagocytosis of aggregated albumin whereas decreases  reflect en- 
hancement of phagocytosis. The T~  of the 5 mg/kg dose of the aggregated albumin was deter- 
mined serially as tolerance to endotoxin pyrogenicity was established. Periodically, the phag- 
ocytic capacity of the RES for I131-1abeled aggregated albumin  (Vm~)  was determined by 
measuring the clearance of both 0.03  and 5 mg/kg doses. For this purpose, the plasma clear- 
ance  (T~)  of  0.03  mg/kg  and  5  mg/kg  doses  of I131-1abeled aggregated  albumin  were 
measured  by  methods  outlined  previously  (14).  The  phagocytic  capacity  of  the  RES 
(Vm~)  was then calculated using the equation (see reference 25) 
Vm~x (mg/kg/min.) = 
39.8 
12.0 T'I/~ -- 11.5 T"I/~ 
where T'~ equals the halftime clearance (minutes) of the 5 mg/kg dose and T"~ equals that 
of the 0.03  mg/kg dose (25).  In the studies with S. typhosa endotoxin, the clearance of ag- 
gregated albumin was always measured approximately 1 hour prior to the injection of endo- 
toxin.  In the Pseudomtmas endotoxin study,  the same relation was observed up  to day 8. 
Thereafter,  no endotoxin was administered  on the day of the clearance determination. All 
subjects were afebrile and asymptomatic at the time each clearance study was performed. 244  MECHANISMS  OF  ENDOTOXIN  TOLERANCE.  II 
RESULTS 
Effect  of Constant  Daily Doses of Endotoxin ot~ RES Phagocytic Activity.- 
Five  normal  subjects  were  given  daily intravenous  injections  of 0.5  #g  S. 
typhosa  endotoxin for 7 days. The fever indices, toxic reactions, and plasma 
clearance rates  of Ira-labeled  aggregated  albumin are  shown in  Text-fig.  1. 
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TExT-FIG.  1. RES phagocytic activity in 5 normal subjects during the acquisition of toler- 
ance to daily intravenous injections of 0.5 #g of S. typhosa endotoxin. The time (minutes) 
required for 50 per cent clearance of S mg/kg of II31-labeled aggregated human serum albumin 
(T~) is employed as the index of RES phagocytic activity. Iso, 1 standard deviation. 
Marked  tolerance was  established  to  the pyrogenic and  toxic effects of the 
endotoxin in  each  subject.  The  ability of the  RES  to  clear  the  aggregated 
albumin, as reflected by the T1/~ value, remained unaltered. 
Effect  of Progressive Increments  in  Dose of Endotoxin  on  RES  Phagocytic 
Activity.--Four subjects were rendered tolerant to Pseudomonas  endotoxin by 
daily intravenous  injections  of  progressively larger  quantities.  The  dose  of 
endotoxin was increased when the toxic subjective reactions to the preceding 
injection reached  a  minimal level. The dosage schedule required  to  achieve 
such  tolerance,  and  the  concomitant  plasma  clearance  rates  of  laal-labeled GREISMAN~ WAGNER,  JR,,  II0~  AND HORNICK  245 
aggregated  albumin for each subject are given in Text-fig. 2. Marked tolerance 
was established;  the fever indices  and subjective reactions in response to 25 
gg Pseudomonas endotoxin on day 1 were greater than that following 250 pg on 
day 30 in each subject; the mean fever indices were 1049 and 798, and the mean 
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TExT-FIo.  2.  RES  phagocytic activity,  measured  by clearance  of Ilal-labled  aggregated 
human serum  albumin,  in four normal subjects during the acquisition of tolerance to daily 
intravenous  injections of increasing quantities of Pseudomona$ endotoxin.  The  mean  fever 
index and  subjective reactions to 25/zg of the endotoxin  on  day  1 were  1049 and 2+ re- 
spectively; the reactions to 250/Jg on day 30 were 798 and 0.S+ respectively. 
subjective reactions  were  2+  and 0.5+,  respectively.  Despite  this acquired 
tolerance,  no increase  in RES phagocytic activity for Imdabeled aggregated 
albumin  was  demonstrable  in  any  subject.  To  exclude  the  possibility  that 
decreased  RES  blood  flow  occurred  which  masked  increases  in  generalized 
RES  phagocytic  capacity  at  the  cellular  level,  serial  clearance  studies  were 246  MECHANISt'S OF ENDOTOXIN TOLERANCE. II 
performed in each subject employing trace quantities  (0.03  mg/kg)  of the I m- 
labeled aggregated albumin.  Alterations  in the clearance of such  trace  quanti- 
ties  of  colloid  would  primarily  reflect  alterations  in  RES  blood  flow  (15). 
Moreover, since the clearance of the trace quantity and of the 5 mg/kg dose of 
aggregated albumin  was measured,  the maximum phagocytic capacity  (Vmax) 
of the RES  could be calculated  for this  colloid  (14).  No evidence of decreased 
TABLE II 
Rdationship  between Tolerance Induced by Daily Intravenous Administration of Pseudomonas 
Endotoxin and Maximum Phagocytic Capacity of the RES (V,~) for Im-Labded 
Aggregated Human Serum Albumin 
Subject 
Mean ±  sE 
Control 
0.77¢ 
(2.8) 
(7. o) 
0.95 
(2.3) 
(5.7) 
0.92 
(2.8) 
(6.3) 
1.07 
(2.3) 
(5.3) 
0.93  ±  0.06 
(2.6  ±  0.15) 
(6.1  ±  0.15) 
Prior endotoxin injections* 
0.53 
(2.0) 
(8.2) 
0.74 
(2.3) 
(6.7) 
0.77 
(2.2) 
(6.4) 
0.85 
(2.1) 
(5.9) 
0.72  ±  0.07 
(2.2  ±  0.07) 
(6.5  ±  0.15) 
17 
0.90 
(2. i) 
(5.7) 
0.71 
(2.4) 
(7.0) 
0.88 
(I  .6) 
(5.3) 
0.83  4-  0.05 
(2.0  ±  0.25) 
(6.0  ±  0.18) 
* See Text-fig. 2 for dose schedule of Pseudomonas endotoxin. 
:~ Maximal phagocytic capacity of the RES for Ilm-labeled aggregated  albumin (mg/kg/ 
rain.)  as calculated  from the T~  clearance  values of 0.03 mg/kg (upper parenthesis)  and 
5 mg/kg (lower parenthesis),  measured  20 minutes later. 
RES perfusion or increase in maximum RES phagocytic capacity was observed 
as tolerance was acquired  (Table II). 
The preceding studies indicate  that generalized increases in RES phagocytic 
capacity in man are not a  requisite for the acquisition  of marked tolerance to 
endotoxin  pyrogenicity.  Further  observations  support  the  concept  that  pyro- 
genic  tolerance  in  man  involves more  specific mechanisms, 
Pattern of Acquisition  of Endotoxin  Tolerance:  Reaction to the Second [njec- 
tion.--When  a  fixed  quantity  of  endotoxin  is  repeatedly  administered  intra- GREISMAN~ WAGNER~ JR.~ IIO~ AND  HORNICK  247 
venously to man, tolerance rapidly develops to its pyrogenic and toxic activities 
(17).  Certain aspects of the pattern of such  tolerance have  not been  empha- 
sized  previously.  Thus,  when  healthy  volunteers  were  challenged  at  daily 
intervals with a  constant dose of the S. typhosa or Pseudomonas  endotoxin, the 
TABLE III 
Pyrogenic and Symptomatic Reactions to a Fixed Dose of Bacterial Endotowin  on Days 1 and 2 
Sub~;ect 
Day 1  Day 2 
Fever  Subjective  Fever  Subjective 
index  reaction  index  reaction 
Change in fever 
mdex 
Salmonella typhosa ondotoxin  (0.125 tzg) 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
Mean ................. 
1250 
1160 
450 
240 
1086 
127 
1092 
376 
442 
637 
716 
645 
685 
0 
1+ 
I+ 
0 
2+ 
0 
2+ 
2+ 
0 
1+ 
0 
1+ 
0.8+ 
1640 
1580 
1400 
1300 
1248 
366 
951 
438 
464 
400 
727 
413 
911 
per cent 
3+  +31 
3+  +36 
3+  +211 
3+  +422 
3+  +15 
1+  +188 
3+  -13 
3+  +16 
0  +5 
0  -37 
1+  +2 
1+  -37 
2+  +70 
Pseudomonas endotoxin  (10 Izg) 
22 
23 
24 
25 
26 
27 
28 
29 
Mean ........ ~  ........ 
652 
721 
510 
560 
1607 
853 
685 
1052 
830 
1+ 
0 
1+ 
1+ 
(25 lag) 
3+ 
1+ 
1+ 
2+ 
1.2+ 
780 
1012 
500 
640 
1780 
870 
770 
731 
885 
2+  +20 
2+  +40 
1+  --2 
1+  +14 
4+  +11 
1+  +2 
1+  -]-13 
2+  --30 
1.8+  +9 
pyrogenic  and  toxic  reactions  associated  with  the  2nd  day  challenge  were 
frequently greater  than  the initial reactions  (Table III).  Such  increments  in 
reactivity on day 2 were highly variable from one subject to the next and bore 
no apparent relation to their reactivity on day  1.  This  enhanced  reaction  to 
endotoxin on  the 2nd  day could not  be attributed  to a  generalized toxic ira, 248  MECHANISMS  OF ENDOTOXIN  TOLERANCE.  II 
pairment of RES phagocytic function; the ability of the RES of control sub- 
jects to clear aggregated albumin on day 2 remained within the range  seen 
during subsequent tolerance (Text-figs. 1 and 2). In contrast, ff the second in- 
jection of endotoxin was delayed for 1 week, tolerance rather  than enhanced 
reactivity was apparent (Table IV). 
Passive Transfer of Tolerance.--The frequent occurrence of exaggerated day 
2  reactions with the  endotoxin preparations  employed in  these  studies per- 
mitted evaluation of the hypothesis (10, 18) that pyrogenic tolerance involves 
the participation of antibody. Pyrogenic reactivity was monitored on day 1, 
and the effect of tolerant plasma on the 2nd day response was then determined. 
Eleven healthy volunteers were  given an initial intravenous injection of  10 
TABLE IV 
Pyrogenic and Symptomatic Reactions to a Fixed Dose of Bacterial Endotoxin 
(0.5 gg S. typhosa Endotoxin) on Days I and 7 
~ean, 
Subject 
30 
31 
32 
33 
34 
35 
36 
Day 1 
Fever 
index 
Fever 
index 
1206  2+ 
913  2+ 
814  1-4- 
650  1-4- 
948  23- 
1127  23- 
1402  33- 
1009  1.93- 
Subjective 
reaction 
1035 
769 
771 
692 
317 
960 
927 
781 
Day 7 
Subjective 
reaction 
1+ 
1+ 
13- 
13- 
0 
1+ 
2+ 
i+ 
Chantge in fever 
Index 
per cen~ 
--i4 
--16 
--5 
3-6 
--67 
--15 
-34 
-21 
gg Pseudomonas endotoxin. Seven hours later, when the pyrogenic and toxic 
reactions subsided, five subjects (mean weight 60 kg) were each infused intra- 
venously with 400 to 500 ml of fresh citrated pyrogen-free plasma pooled from 
two to three normal donors. The six other subjects (mean weight 58 kg) each 
received similar volumes of pooled fresh citrated plasma obtained from tolerant 
donors drawn 24 hours after the seventh daily intravenous injection of 0.125 
~tg S. typhosa endotoxin; this quantity of S. typhosa endotoxin possessed pyro- 
genic potency comparable to the 10/~g Pseudomonas endotoxin. In one subject, 
the tolerant plasma evoked a  shaking chill and a  febrile reaction beginning 1 
hour after infusion; the fever peaked at 3 hours and returned to baseline by 7 
hours. The pyrogen was not identified. The following morning all subjects were 
afebrile and were again given 10 #g of Pseudomonas endotoxin intravenously. 
The results are shown in Table V. The pyrogenic reaction following the second 
injection of Pseudomonas  endotoxin was increased a  mean of 23 per cent in GREISMAN, WAGNER, JR., II0~ AND HORNICK  ¢~:  ~2~ 
the subjects receiving normal plasma, and the toxic reactions increased from a 
mean  of  1.0  -}-  to  1.8+.  Thus,  normal homologous  citrated plasma did not 
inhibit the exaggerated 2nd day reaction. In contrast, a  25 per cent reduction 
TABLE V 
Effect of Passi¢e Transfer of Normal and Tolerant Plasma on Responsiveness 
to 10 #g Pseudomonas Endotoxin* 
Subject 
Day 1 
Fever  Subjective 
index  reaction 
Fever 
index 
Day 2  .I 
Subjective 
reaction 
Change in fever 
index 
Recipients of normal plasma 
Mean. 
37 
38 
39 
40 
41 
1063 
882 
465 
995 
570 
795 
1+ 
1+ 
0 
2+ 
1+ 
1+ 
1038 
1202 
552 
1080 
875 
950 
per ¢e~ 
2+  -2 
2+  -]-36 
0  +19 
3+  +10 
2+  +54 
1.8-b  -6235 
(as  4-  9.8) 
Recipients of tolerant plasma 
Mean. 
42 
43 
44 
45 
46 
1114 
1005 
581 
813 
765 
856 
3+ 
2+ 
1+ 
2+ 
2+ 
2+ 
834 
687 
434 
719 
513 
637 
2+  --25 
1+  --32 
0  --25 
1-b  --12 
0  --33 
o.8+  -25~ 
(sz  q-  3.9) 
Reciter of tolerant plasma q- pyrogen 
b  ~  m 
+81 
~  [  I 
* Baseline  responses to the Pseudomonas endotoxin were obtained on day 1, and 400 to 
500 ml of fresh citrated plasma was infused immediately after these control studies. Testing 
with the Pseudomonas endotoxin was then repeated on day 2. Plasma from tolerant donors 
was obtained 24 hours after the 7th daily intravenous injection of 0.125 #g S. typhosa endo- 
toxin. 
P  <  0.005. 
occurred  in  the  pyrogenic  reaction  to  the  second  injection  of  Pseudomonas 
endotoxin in the subjects given plasma from donors tolerant to S. typhosa endo- 
toxin. This inhibition of fever by the plasma from tolerant donors was highly 
significant  (p  <  0.005);  in  addition,  the  toxic subjective reactions were  also 102" 
h 
"..101 
bJ 
n- 
l-'- 
<  I00 
lIE 
b.I 
Q. 
:E 
99- 
_1 
F- 
0 
"'  98-  n,- 
DD  No.I  AGE  25 
FEVER 
S.TYPHOSA  INDEX 
X....,.'X'"'"'X.  ./- 
o/zs..g  .........  ""/x ....... x. ..... 
.......  .X  ........  /  ....  ,X'.-..X.......~ .................  433 
~.-.....~...."'~  w.~.,-,,,l-  ~ -  .-,x.,._  .~ __x,. _.___  _~  382 
o/25.ug  /" 
,~  ~  --K----)¢'  /"  DAY  SE_VE.RITY  OF 
~,,r  ~  SYMPTOMS 
X----)(  " -  ''K  /  /'It  INJECTION  SYIV 
~)~  ........  (617/62)  O 
301h DALLY INJECTION 
o/ms,.g  ~  ~,  --.  (?/s/62) 
i  " ~  "1  t  31st DALLY INJECTION 
I  [  I  I  I  I  I  I 
0  I  2  3  4  5  6  7 
TIME  (HOURS) 
TExT-Fzo. 3 
D D No.2  AGE30 
I04. 
103' 
,02.  J 
S. TYPHOSA  FEVER 
=  ~  /  /  -,,  ",,,,..  ,NoEx 
lo,.  ~  i  '~ 
tit  /  "....°)f.,. 
o.w  ~---W--~---K  "'W"'"""'"..  x 1688  ~,oo-  /  .~--~-~-.. ..........  :.. 
/  s~"~  n  -',(--  "-R-'-  ")("  ~  ----  K 
/~x" 
":"~'--'~(""~  I  DAY  I SEyER,TY OF  •  "  SYMPTOMS  E "  o~.,,,~  ........... ":;,,N~ECT,ONI  S, .~ 
~lf~  ..........  (617162)  ~T 
=  -,  7  ~  [  (  ,,,=,~,.~CTIO.  I  O 
NIES.-~ ~  ~.."~  I  I  .....  (716162)  I 
Ag  X,----'X  0>125.ug  s==t DALLY INJECTIOI, 
98-  ,~  ,  ~  (7/7,,62)  ,  3+ 
o/25,~g 
I  I  I  I  I  I  I  I 
0  I  2  3  4  5  6  7 
TIME  (HOURS) 
T~xT-Fzo.  3 b 
Tm~T-FzGs.  3 a,  3 b,  and 3 ¢.  Patterns of tolerance reversal produced  by dividing  the 
endotoxin dose.  Tolerance was  induced  by 30  daily  intravenous injections o£  0.25  #g  S. 
typhosc~ endotoxin; on day- 31 hsE the dose was given and the second half dose was injected 2 
hours later. DD, divided dose. 
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mitigated.  The  one subject that  received tolerant  plasma with pyrogen was 
not protected on day 2 (Table V). 
Reversal of Tolerance with Divided Doses of Endotoxin.--To further test the 
concept  that  tolerance  involves  the  participation  of  antibody,  ten  normal 
subjects were rendered highly tolerant  by 30  daily intravenous  injections of 
0.25  pg of S.  typhosa  endotoxin.  On day 31, half  the dose of endotoxin was 
administered and 2 hours later the remainder.  If antibody were concerned with 
tolerance, the initial injection should reduce the titer and the second portion 
might now be free to induce toxic reactions (Danysz phenomenon). Text-figs. 
3 a, 3 b, and 3 c represent the various patterns found in nine of ten subjects. 
Tolerance was generally reversed by this technique. In the subject depicted in 
Text-fig.  3 a, the reaction to the divided dose on day 31 was actually greater 
than to the initial single dose. To verify that such reversal of tolerance was not 
based upon general  depression of RES phagocytic activity, studies were per- 
formed  in  six  control  subjects.  No  depression  of RES  phagocytic activity, 
measured  by l~-labeled  aggregated  albumin  clearances,  was  detectable  2 
hours after the initial injection of endotoxin. Thus the mean control clearance 
of 5 mg/kg IZ~Z-labeled  aggregated albumin (T1/~) was 5.6 (sv. 4-0.20) and 5.8 
(s~. 4-0.30) minutes on days 3 and 2 respectively prior to endotoxin; 2 hours 
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Reversal of Tolerance by Substitution  of a Comparably Pyrogenic Quantity  of a 
Heterologous Bacterial Endotoxin 
Subject  Day  Endotoxin*  Fever index  Subjective  reaction 
24 
25 
48 
49 
50 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
#g 
P  10 
10 
20 
5O 
100 
100 
200 
200 
S  2.5 
P  200 
P  10 
10 
20 
50 
100 
100 
200 
200 
S  2.5 
P  200 
510 
500 
438 
608 
675 
610 
837 
677 
320 
1440 
560 
640 
461 
608 
838 
765 
1021 
493 
339 
1177 
1  P 
2 
3 
4 
5  S 
6  P 
1  P 
2 
3 
4 
5  S 
6  P 
1  P 
2 
3 
4 
5  S 
6  P 
10  1010 
10 
10  480 
10  485 
0.125  300 
10  720 
10  1120 
10 
10  770 
10  450 
0.125  310 
10  1030 
10  590 
10 
10  68O 
10  360 
0.125  280 
10  690 
1+ 
1+ 
0 
0 
0 
0 
1+ 
0 
0 
4+ 
1+ 
1+ 
0 
0 
0 
0 
1+ 
0 
0 
4+ 
2-+- 
0 
0 
0 
1+ 
3+ 
0 
0 
0 
3+ 
1+ 
2+ 
0 
0 
2+ 
* P, .Pseudomonas endotoxin; S, Salmonella typhosa endotoxin. 
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253 
Subject 
51 
52 
Day 
1 
2 
3 
4 
5, 6 
Endotoxin* 
P  lO 
4o 
50 
200 
Fever index 
473 
1024 
780 
974 
7  S 
8  S 
1  P 
2 
3 
4 
5, 6 
7  S 
8  S 
1.0 
0.5 
10 
4O 
50 
200 
1.0 
0.5 
1591 
2172 
327 
863 
80 
311 
838 
1698 
Subjective 
reac~on 
0 
2+ 
0 
0 
3+ 
4+ 
0 
2+ 
0 
0 
2+ 
4+ 
after an initial intravenous injection of 0.5 ~g S. typhosa  endotoxin, the T~ 
was 5.4 (s~. 4-0.16) minutes. The reversal of tolerance by the divided dose also 
could not be attributed to alterations in baseline temperatures. Although some 
rise following the initial half dose of endotoxin is seen in these subjects, other 
subjects with acquired tolerance during convalescence from typhoid fever (to 
be reported subsequently) exhibited reversals of tolerance without the slightest 
rise in baseline temperature after the initial half dose of endotoxin. 
Specificity  of Endotoxin  Tolerance.--Seven  subjects were rendered tolerant 
to  Pseudomonas  endotoxin by single daily intravenous injections for 4  to  8 
days. Each subject was then given S. typhosa endotoxin in a dose comparably 
pyrogenic to that of the preceding dose of Pseudomonas endotoxin. As expected 
from the cross-tolerance known to occur in man (17),  each subject  exhibited 
tolerance to this heterologous endotoxin. However, upon testing on the follow- 
ing day with either the original or the heterologous endotoxin, tolerance was 
definitely impaired  (Table  VI).  This  ability of the  heterologous S.  typhosa 
endotoxin to reverse tolerance is highly significant when compared with the 
consistent absence of such  enhanced reactions  in groups  of control subjects 
given  comparable  series  of injections of  the  homologous  endotoxin only (p 
<  0.001). Similar attempts were made to reverse tolerance in five other subjects 
rendered tolerant to 0.25  #g S. typhosa  endotoxin for 25 days. A  comparably 
pyrogenic quantity of Pseudomonas  endotoxin  (20  ug)  was  administered on 
day 26,  and testing was resumed with the S.  typhosa  endotoxin on day 27. 
With this procedure, tolerance could not be impaired in any subject. The mean 
fever index on day 25 following the S. typhosa endotoxin was 320 (SE 4-35), the 254  MECHANISMS  OF  ENDOTOXIN  TOLERANCE.  II 
response to the Pseudomonas endotoxin on day 26 was 350  (SE -+-63), and the 
reaction to the S. typhosa endotoxin on day 27 was 312  (SE  +46). 
Dermal  Reactivity  to  Endotoxin.--The  intradermal  injection  of  varying 
quantities  of S.  typhosa  endotoxin  into fifteen normal volunteers  consistently 
resulted  in  a  gross inflammatory reaction.  The response  became  visible  after 
TABLE VII 
Effect of Induced Tolerance to S. Typhosa Endotoxin on 
Dermal Reactivity to this Endotoxin* 
Time after intradermzl inoculation 
0.I ml intra- 
dermal S.  typt~sa  4 hrs.  15 to 24 hrs.  36 to 48 hrs. 
endotoxin 
i 
Control  Tolerant  Control  Tolerant  Control  /  Tolerant 
Subject 53 
0.005 
0.0005 
0.00005 
Saline 
100 (1+):~  81 (1+) 
25 (4-)  36 (1+) 
40 (4-)  4  0 (1+) 
484 (3+) I 
36 (2+) I 
9 (1+) 
0 
4OO (3+) I 
40O (3+) I 
400 (3+) I 
0 
900 (2+) I 
100 (1+) I 
36 (1+) I 
0 
900 (2+) I 
525 (1+) I 
900 (1+) I 
0 
Subject 54 
0.005  225 (1+)  144 (1+)  225 (2+) I  225 (3+) I  100 (1+) I  100 (2+)I 
0.0005  169 (1+)  25 (1+)  25 (1+) I  100 (3+) I  25 (1+) I  -- 
0.00005  9 (4-)  25 (1+)  9 (4-)  64 (3+) I  4 (4-)  25 (2+) I 
Saline  0  0  0  0  0  0 
* Tolerance induced by 13 daily intravenous injections of increasing dosages of S. typhosa 
endotoxin and dermal testing performed on day --1 (control) and day 14. The fever index 
following 0.5 #g endotoxin on day 1 was 1860 and 1680 in subjects 53 and 54 respectively; on 
day 13 the response to 2.0/zg endotoxin was 200 and 220 respectively. 
:~ The first  figure represents  the area  index  of the inflammatory  reaction  obtained  by 
multiplying  the largest cross diameters  (ram). The values in parenthesis  indicate  the gross 
intensity of the erythematous  reaction: -4-, minimal; l+, mild; 2-1-, moderate; 3+, marked. 
I, induration. 
1  hour  and  generally  attained  maximum  size  by  approximately  5  hours,  al- 
though  in  three  subjects  the  maximum  reaction  was  not  seen  until  approxi- 
mately 15 hours. This sequence of events is comparable to that reported with 
Esckerichia coli endotoxin  (19).  The effect of induced tolerance on the dermal 
inflammatory  response  is  illustrated  in  Table  VII.  Marked  tolerance  to  the 
pyrogenic activity of intravenously administered  endotoxin was not associated 
with impairment of the local inflammatory response. On the contrary, enhanced GREISMAN,  WAGNER, JR.,  II0,  AND  HORNICK  255 
local reactivity developed which was especially evident upon testing with the 
smaller doses of endotoxin. 
DISCUSSION 
Whenever  bacterial  endotoxins  are  administered  intravenously  at daily 
intervals,  tolerance is  acquired  rapidly to  their  toxic and pyrogenic effects. 
While the mechanism for this tolerance in man is unknown, in the experimental 
animal it has been presumed to be mediated by enhanced ability of the RES 
to clear injected endotoxin from the circulation (see  introductory statements). 
Several lines of evidence have supported the concept that the enhanced rate of 
endotoxin  clearance, and  hence  tolerance,  could  be  attributed  to  a  non- 
specific  stimulation  of  RES  phagocytic activity:  (a)  Tolerant  animals  also 
dear  various  inert  colloidal particles  at  enhanced  rates  (10,  20);  (b)  RES 
blockade with a  variety of inert  colloids  appeared  to  abolish  tolerance  (1); 
(c)  Immunologic mechanisms did not appear  responsible since  tolerance ex- 
tended  to  endotoxins  derived  from  heterologous  bacterial  species  (17,  21), 
could not be readily transferred with serum (21-23), and lapsed after cessation 
of endotoxin administration despite  elevated specific  O  agglutinin titers  (17, 
21).  In more recent studies in which transfer of significant tolerance was ac- 
complished with serum, it was correlated with an increased ability of the RES 
to  clear  colloidal carbon  (24).  In  contrast,  the present observations in man 
indicate that  tolerance is  not dependent upon  generalized increases  in  RES 
phagocytic activity. Despite the induction of high levels of pyrogenic tolerance 
to constant doses of S. typhosa endotoxin or to progressively larger quantities 
of Pseudomonas endotoxin, no overt increases were detectable in the ability of 
the RES to clear an unrelated colloidal material, Ira-labeled heat-aggregated 
human serum albumin. The rate of uptake of such colloidal particles provides 
one  index  of  non-specific  or  generalized  RES  phagocytic activity since  the 
colloidal particles are immunologically inert in man and the kinetics of their 
clearance parallel those of other  inert  colloids  such as  carbon  (14,  15). The 
failure to demonstrate accelerated clearance of aggregated albumin could not 
be attributed to inability of this material to detect alterations of RES phago- 
cytic activity in man; significant enhancement and depression of its clearance 
have been observed during various infectious illnesses  (25).  Moreover, studies 
with trace  quantities  of the Pl-labeled  aggregated  albumin,  in  conjunction 
with larger quantities, permitted precise calculation of  the maximum phago- 
cytic capacity of the RES for this colloid (25);  no increases were found during 
the  acquisitiorL  of  pyrogenic  tolerance.  This  precludes  the  possibility  that 
decreased RES blood flow during tolerance masked a  generalized increase in 
RES phagocytic capacity at the cellular level. 
The  absence  of generalized increases  in  RES  phagocytic activity in  man 
contrasts with that observed in rabbits rendered comparably tolerant  to  the 256  MECHANISMS  OF  ENDOTOXIN  TOLERANCE.  II 
pyrogenic activity of endotoxin (10). It seems likely that this discrepancy stems 
in  part  from  the  relatively greater  responsiveness  of  man  to  the  pyrogenic 
effects  of  endotoxin)  Therefore,  during  the  administration  of  comparably 
pyrogenic  quantities  of  endotoxin,  considerably  lower  doses  of  endotoxin  in 
terms of mg/kg are given to man. It would be desirable to confirm the concept 
that quantities of endotoxin of a  magnitude  (mg/kg) that stimulate the  gen- 
eralized phagocytic activity of the RES in animal species would also do so  in 
man, but such studies cannot be safely undertaken. 
Certain  other observations relate to the mechanism of endotoxin  tolerance 
in man. In contrast to the development of tolerance in the rabbit, the pyrogenic 
and toxic reactions were enhanced in some subjects when the same quantity of 
endotoxin was administered 24 hours after the initial dose. Although the nature 
of the endotoxin preparation may influence its occurrence,--exaggerated day 2 
reactions were not reported with S. abortus equi (pyrexal) (27),--it is unlikely 
that this hyperreactivity was peculiar to the endotoxin preparations employed 
in the present studies; exaggerated day 2 pyrogenic reactions in man have been 
documented graphically with other endotoxin-containing preparations  (28-30). 
This hyperreactivity on day 2 bore no apparent relation to the intensity of the 
preceding  initial  reaction.  It  could  not  be  attributed  to  a  generalized  toxic 
depression of RES phagocytic activity since the clearance rates of I18~-labeled 
aggregated albumin at  this  time consistently remained within  the range seen 
during  subsequent  tolerance. An alternative hypothesis for the hyperreactive 
day  2  response  and  its  relationship  to  endotoxin  tolerance  in  man  may be 
inferred from the available data: 
The toxic activities of endotoxin  depend,  in part at least, upon acquired hyper- 
sensitivity of the host. This has been emphasized by Stetson  (31) and is consistent 
with the observations of Schaedler and Dubos (32), and Watson and Kim (18). These 
latter investigators recently presented evidence supporting the concept that pyrogenic 
tolerance in the rabbit is based upon the induction  of protective antibodies capable of 
assisting  the RES in clearance  and destruction of endotoxin; this presumably reduces 
the pyrogen response by preventing interaction of the endotoxin  with more vulnerable 
sensitized  cells (18).  It is equally conceivable  that the protective antibody acts by 
competition with other antibodies which form more toxic complexes with endotoxin 
(33). The findings in  man are consistent with these theses. Thus it seems reasonable 
that the pyrogenic reaction following intravenous administration of endotoxin to man 
For example, 0.5 #g of an S. typhosa endotoxin preparation produced moderate to severe 
toxic reactions and a mean fever index of 920 in 23 normal volunteers weighing an average of 
68 kg. This represents 0.007 #g/kg of endotoxin. In contrast, extrapolation from dose-response 
data obtained in three groups of normal rabbits  (five animals per group) indicated that 0.7 
#g/kg of this same endotoxin would be required to produce comparable fever indices in normal 
rabbits weighing 1 kg. Such enhanced responsiveness of man as compared with rabbits to 
dosages of endotoxin exceeding minimum pyrogenic levels has been documented previously 
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may also be mediated in part by hypersensitivity reactions. 4 The severity of the pyro- 
genic reaction following an initial injection of endotoxin would depend upon the degree 
of hypersensitivity in relation to the titer of protective antibody. Following this initial 
injection,  the  protective  antibody  titer  may fall.  Significant  reductions  of specific 
antibody titers after an initial intravenous injection of endotoxin have been demon- 
strated in mice (38). Repletion of protective antibody may be incomplete by 24 hours, 
and hyperreactivity now ensues.  Since  the rate of antibody repletion would be influ- 
enced by prior immunologic experience of the host and by antigenic potency of the 
endotoxin,  variability  of  the hyperreactive response  might be anticipated  between 
individuals and endotoxin preparations.  In contrast, if the second injection of endo- 
toxin be delayed for 1 week, sufficient time is permitted for augmented titers of pro- 
tective antibody, and tolerance rather than hyperreactivity is now evident. 
As endotoxin is administered  repeatedly to man,  the rate of protective antibody 
production is stimulated progressively, and augmented titers develop within 24 hours. 
When endotoxln is injected at such intervals,  the resulting antigen-antibody aggre- 
gates are cleared by the RES at accelerated rates, thus reducing the formation of more 
toxic  antibody-antigen  complexes  and/or  protecting  more  vulnerable  sensitized 
host cells  against  injury.  This  is  supported  by  current  studies  in  ten  volunteers 
which indicate significant acceleration of clearance of Cr~l-labeled Pseudomonas  endo- 
toxin in association with the acquisition of pyrogenic tolerance (70).  The  protection 
observed by passive transfer of plasma drawn 24 hours after repeated daily injections 
of endotoxin is also consistent with this thesis.  Moreover, if half the dose of endotoxin 
is given after  tolerance has been established  by daily intravenous injections,  and 2 
hours later  the  second half  is  administered,  tolerance may be  reversed.  This  phe- 
nomenon parallels the effect described with two closely spaced full doses of endotoxin 
(39-41)  and indicates  that tolerance is not based upon desensitization  of sensitized 
cells  or exhaustion of factors required for pyrogenic reactivity. Although the mech- 
anism for this response is unknown, it may be related in part to transient depletion of 
the protective  antibody following the  initial  dose of endotoxin; indeed,  slowing of 
clearance  of  CrSl-labeled  Pseudomonas  endotoxin  has  been  observed  in  association 
with the hyperreactive response at 2 hours (70).  Certainly, the reversal of tolerance 
by the second half dose cannot be attributed simply to shifts in baseline temperature 
or to generalized RES depression induced by the first dose. 
One additional series of observations is consonant with the immunologic interpreta- 
tion of tolerance. When after 4 to 8 days of daily intravenous injections of Pseudomonas 
endotoxin, a comparably pyrogenic dose of S. typhosa endotoxin was injected, cross- 
tolerance to this heterologous preparation was observed. As suggested by the present 
passive  transfer studies and  by observations in animals  (10,  18, 42), such tolerance 
4 The inflammatory and indurative  responses in normal man following intradermal  inocu- 
lation with E. coli endotoxin (19) and with S. typhosa endotoxin are compatible with a delayed 
hypersensitivity  reaction accelerated by the presence of circulating antibody (34). Moreover, 
febrile responses comparable to those elicited by endotoxin can be produced in man during 
systemic hypersensitivity  reactions  to tuberculin  (35) and  during  immune hemolysis  (36). 
Finally,  Brucdla endotoxin induces little fever in normal man, whereas once sensitized with 
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can be explained by the ability of protective antibody to cross-react with heterologous 
endotoxins. However, on the following day, tolerance was significantly impaired either 
to the original or to the heterologous endotoxin. While the mechanism for this effect is 
currently under study, it may reflect depletion of cross-reactive protective  antibody 
by the heterologous endotoxin, associated with inadequate repletion of such antibody 
within 24 hours. In any case, the findings point to the high specificity of tolerance. 
Certainly, if pyrogenic tolerance were based simply upon non-specific RES stimulation 
by endotoxin, it should make little difference whether the homologous or heterologous 
endotoxin were injected  daily provided  comparably  pyrogenic doses were adminis- 
tered. It should be emphasized that the conditions employed to demonstrate impair- 
ment of tolerance by heterologous endotoxins are critical. After several weeks of daily 
intravenous  injections of S.  typkosa endotoxin, a comparably pyrogenic quantity of 
Pseudomonas endotoxin consistently failed to reverse tolerance 24 hours later. 
The observation that the dermal inflammatory response to endotoxin is not miti- 
gated during tolerance lends additional  support  to the concept that pyrogenic toler- 
ance is not based upon exhaustion of host reactivity. Rather such data are consistent 
with the concept that the specific antibody which participates  in tolerance may actu- 
ally intensify cutaneous responsiveness to this material  (34). 
The  present  evidence  that  tolerance  to  bacterial  endotoxins  in  man  is 
mediated by specific  mechanisms rather  than by generalized stimulation of 
RES  phagocytic activity is  in  accord  with  other  clinical  and  experimental 
observations. Thus Westphal observed that tolerance is difficult to induce in 
man  when  highly purified  preparations  are  employed  (43).  These  findings, 
together  with  the  observation  that  heat-inactivated  endotoxin retains  both 
antigenicity and the ability to induce tolerance (42), suggest that antigenicity, 
not toxicity, is the major determinant of pyrogenic tolerance in man. Similar 
conclusions were reached in  the mouse and rabbit  employing chemically in- 
activated  endotoxin  (44).  Other  studies  utilizing  fatty acids  (45),  zymosan 
(46), graft ~ersus host reactions (47), and infection with Mycobacterium tubercu- 
losis  (48)  indicate that generalized increases in  RES  phagocytic activity, as 
reflected by enhanced ability to  clear colloidal carbon,  do not per  se  confer 
tolerance to  endotoxin. Indeed, despite increases in generalized RES  phago- 
cytic activity in  man  during  typhoid fever and  tularemia,  tolerance  is  not 
observed;  rather  preinduced  tolerance  is  completely  suppressed  (49).  Con- 
versely,  depression  of  generalized  RES  phagocytic  activity  in  man  during 
sandfly fever infection does not impair tolerance  (49).  Finally, depression of 
generalized  RES  phagocytic  activity in  the  rabbit  by  thorotrast  does  not 
abolish tolerance; the persistence of tolerance can be attributed to circulating 
opsonins capable of cross-reacting with endotoxins from heterologous bacterial 
species  (10).  The  temporal  correlation  between  the  appearance  and  disap- 
pearance  of  pyrogenic  tolerance  and  circulating  protective  factors  (50-52) 
supports  this  hypothesis. 
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in animals  by Boivin and Mesrobeanu (53-55),  Zahl and Hutner (56), Dubos 
and Schaedler  (57),  Mergenhagen and Jensen (58), and Wharton and  Creech 
(42). The initial four groups of investigators showed that  tolerance was most 
marked  against  the  specific  endotoxin  preparation  employed to  induce  the 
tolerant state. The latter investigators demonstrated  that  tolerance could be 
transferred with the gamma globulin  fraction of serum from tolerant donors. 
Such passive protection was dependent upon the globulin concentrations trans- 
ferred in relation to the quantity of endotoxin administered,  and was maximum 
for homologous endotoxins;  only with higher concentrations of gamma globulin 
could  cross-protection  against  heterologous  endotoxins  be  demonstrated. 
Moreover, using single injections of endotoxin and passive transfer techniques, 
protective humoral factors could be dissociated from O agglutinating antibody; 
the titer of the former increased  and decreased more rapidly than the latter. 
It was postulated that endotoxin contains two separate antigenic  factors, one 
the toxic factor which evoked protective antibody, the other responsible  for 
eliciting  non-protective O-agglutinating  antibody. The appearance of a variety 
of  antibodies  in  response  to  endotoxin  administration,  including  an  early 
occurring  non-precipitating  type, has  been verified  (34,  59,  60)  and  Braude 
et al.  (61) recently demonstrated the ability of non-precipitating  antibody to 
inhibit  endotoxin pyrogenicity. These observations probably account for the 
lapse of tolerance in  man  and  rabbits  after  discontinuing  administration  of 
endotoxin despite elevated specific O agglutinin  titers (17, 21). Current evidence 
indicates  that  macroglobulin  (19S)  antibody meets  the requirements  for the 
protective antibody since it characterizes the response  to particulate antigens 
with high carbohydrate content and appears and disappears more rapidly than 
7S globulin antibodies  (62, 63).  Moreover,  19S antibody can be produced in 
subjects with hypogammaglobulinemia (64) and could contribute to the reported 
ability of such persons to acquire tolerance (30). 
While the present studies in man support the concept that pyrogenic tolerance 
is mediated by specific antibody acting to facilitate the uptake and destruction 
of endotoxin by the RES, it  is not meant  to imply that  antibody induction 
constitutes the sole alteration responsible for tolerance.  There is now evidence 
that the RES of man, as in animals,  consists of heterogeneous cell populations 
with highly varied preferences  for the phagocytosis of particulate and colloidal 
substances (65-69). The importance of selective stimulation  of those cellular 
components of the RES which preferentially phagocytize or inactivate  endo- 
toxin during  tolerance remains  to be defined. 
SUMMARY 
Healthy male volunteers were rendered tolerant to the pyrogenic and toxic 
activities of bacterial endotoxin by daily intravenous injections.  Five subjects 
were given 0.5 ~g Salmonella  typhosa  endotoxin for 7 days; four subjects were 260  MECHANISMS  OF  ENDOTOXIN  TOLERANCE.  II 
given Pseudomonas endotoxin,  increasing over a  period of 30 days from 25  to 
250 ~g. Reticuloendothelial system (RES) phagocytic activity was assessed by 
serial measurements of the  clearance of I131-1abeled aggregated human serum 
albumin. In no subject was an increase in RES phagocytic activity detectable. 
Such  negative findings could not be attributed  to decreased RES blood flow. 
--Additional studies on the pyrogenic responses of man to various schedules of 
endotoxin administration  revealed:  (a)  Hyperreacfivity of some subjects to a 
second  injection  of  endotoxin  administered  24  hours  after  the  initial  dose; 
(b)  prevention  of such  hyperreactivity by plasma from donors  tolerant  to  a 
heterologous endotoxin, but not from normal donors; (c) reduced reactivity to a 
second injection of endotoxin given 7 days after the initial dose; (d) reversal of 
induced  tolerance by administration of half the dose of endotoxin followed 2 
hours later by the second half; (e) reversal of induced tolerance 24 hours after 
administration of a  heterologous endotoxin;  (f) enhanced dermal reactivity to 
endotoxin  induced  inflammation during  tolerance. 
The  observations are  consistent  with  the  hypothesis  that tolerance  to  the 
pyrogenic activity of endotoxin in man is not based upon generalized enhance- 
ment of RES  phagocytic activity or exhaustion of host  reactivity but  rather 
involves the  participation  of specific antibody which assists  the  RES  in  the 
clearance and inactivation of the endotoxin molecule. 
The authors express their deepest appreciation to the volunteers who contributed so faith- 
fully to these studies, to Mr. Paul Sharpley, R.N. who assisted in the care of these patients, 
to Mr. James W. Curran, Commissioner of the  Maryland Department  of Correction, Mr. 
William F. Steiner, Chief Warden of the Maryland House of Correction, and to the other 
officials of the Maryland House of Correction for their generous cooperation and interest, 
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PLATE 16 
FIG.  1.  Scintillation  scan  of a  normal subject illustrating  the concentration of 
radioactivity in the liver following intravenous administration of a trace dose (0.025 
mg/kg) of P~-labeled  aggregated  human serum albumin. THE  JOURNAL OF  EXPERIMENTAL  MEDICINE  VOL. 119  PLATE  16 
(Greisman et al.: Mechanisms of endotoxin tolerance. II) PLATE  1  7 
FIG.  2.  Scintillation scan  of  a  normal  subject  illustrating  the  concentration of 
radioactivity in both  the liver and spleen following intravenous administration of a 
large dose (50 mg/kg) of I131-1abeled aggregated human serum albumin. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 119  PLATE 17 
(Greisman et al.: Mechanisms of endotoxin tolerance. II) 